1. Home
  2. OGN vs ICHR Comparison

OGN vs ICHR Comparison

Compare OGN & ICHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$5.85

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo Ichor Holdings

ICHR

Ichor Holdings

HOLD

Current Price

$44.78

Market Cap

1.6B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
OGN
ICHR
Founded
1923
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.6B
IPO Year
2020
2016

Fundamental Metrics

Financial Performance
Metric
OGN
ICHR
Price
$5.85
$44.78
Analyst Decision
Hold
Strong Buy
Analyst Count
4
6
Target Price
$11.75
$45.67
AVG Volume (30 Days)
3.0M
636.3K
Earning Date
04-30-2026
05-04-2026
Dividend Yield
1.32%
N/A
EPS Growth
N/A
N/A
EPS
0.72
N/A
Revenue
$6,216,000,000.00
$947,652,000.00
Revenue This Year
$0.42
$19.98
Revenue Next Year
$1.67
$15.92
P/E Ratio
$8.42
N/A
Revenue Growth
N/A
11.61
52 Week Low
$5.76
$13.15
52 Week High
$14.94
$55.00

Technical Indicators

Market Signals
Indicator
OGN
ICHR
Relative Strength Index (RSI) 25.56 49.62
Support Level N/A $15.74
Resistance Level $7.87 $55.00
Average True Range (ATR) 0.22 3.39
MACD 0.00 -0.34
Stochastic Oscillator 10.00 31.89

Price Performance

Historical Comparison
OGN
ICHR

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

About ICHR Ichor Holdings

Ichor Holdings Ltd designs, engineers, and manufactures critical fluid delivery subsystems and components mainly for semiconductor capital equipment, along with solutions for defense/aerospace and medical industries. Its product portfolio includes gas and chemical delivery subsystems that enable precise delivery, monitoring, and control of specialized gases and reactive liquid chemistries used in semiconductor manufacturing processes such as etch, electroplating, and cleaning. The company also provides precision-machined components, weldments, e-beam and laser-welded components, as well as precision vacuum and hydrogen brazing. Geographically, the company operates across the United States, Singapore, Europe, and other regions, with Singapore contributing the majority of revenue.

Share on Social Networks: